PSY6202 - Psychopharmacology and advanced psychopathology - 2019

0 points, SCA Band 1, 0.000 EFTSL

Postgraduate - Unit

Refer to the specific census and withdrawal dates for the semester(s) in which this unit is offered.

Faculty

Medicine, Nursing and Health Sciences

Organisational Unit

School of Psychological Sciences

Chief examiner(s)

Associate Professor Antonio Verdejo-Garcia

Coordinator(s)

Associate Professor Antonio Verdejo-Garcia

Unit guides

Offered

Clayton

  • Second semester 2019 (On-campus)

Synopsis

This unit aims to provide an overview of the neuropsychopharmacology of drugs, and of the main drugs used in the treatment of mental health and neurological disorders.

Outcomes

On completion of this unit students will:

  1. Understand the basic concepts of psychopharmacology with particular reference to recent advances in the fields of psychiatric medication, cognitive enhancers and neuroprotective agents, and substance abuse;
  2. Have a broad understanding of commonly prescribed psychoactive drugs, legal and illegal drugs and other commonly abused substances;
  3. Be able to comment on the likely physiological and psychological effects in a particular individual of a specific drug (together with possible drug interactions), and to prepare a written report on the topic;
  4. Be able to critically think about current issues in clinical psychopharmacology and in research concerning treatment approaches;
  5. Have a broader knowledge of and diagnostic skills in psychiatric disorders, specifically in bereavement and delirium, from attendance at 2 Psychopathology II lectures.

Assessment

Project Presentation (30%)

Take-home Psychopharmacology Test (70%)

This unit applies to the following area(s) of study